Investigating the effects of IDO1, PTGS2, and TGF-β1 overexpression on immunomodulatory properties of hTERT-MSCs and their extracellular vesicles
Abstract The therapeutic potential of mesenchymal stem cells (MSCs) is out of the question. Yet, recent drawbacks have resulted in a strategic shift towards the application of MSC-derived cell-free products such as extracellular vesicles (EVs). Recent reports revealed that functional properties of M...
Guardado en:
Autores principales: | Azadeh Haghighitalab, Maryam M. Matin, Ahmad Amin, Shima Minaee, Hamid Reza Bidkhori, Thorsten R. Doeppner, Ahmad Reza Bahrami |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/df360aec35ab4d7e9dd012d6f614fd67 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CDK1 dependent phosphorylation of hTERT contributes to cancer progression
por: Mami Yasukawa, et al.
Publicado: (2020) -
Functional and gene expression analysis of hTERT overexpressed endothelial cells
por: Haruna Takano, et al.
Publicado: (2008) -
NOVA1 regulates hTERT splicing and cell growth in non-small cell lung cancer
por: Andrew T. Ludlow, et al.
Publicado: (2018) -
hTERT-immortalized gingival fibroblasts respond to cytokines but fail to mimic primary cell responses to Porphyromonas gingivalis
por: Katarzyna B. Lagosz-Cwik, et al.
Publicado: (2021) -
The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells.
por: Christiane A Opitz, et al.
Publicado: (2011)